Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

The global water agenda is outdated and narrow and is framed mainly as a downstream impact sector. Scientists must step up to help the world recognize water as an opportunity sector and to design a ...

Every week, The President’s Inbox podcast, hosted by Distinguished Fellow James M. Lindsay, goes beyond the subject line with leading foreign policy experts to explore how the United States should ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...